MedTrace Logo

Cardiological Drug Classes And Falls in Older Adults

NCT07150754 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2025-09-02

No results posted yet for this study

Summary

Heat failure is a fast gowing health issue with a rising incidence in older adults. Recommendations have recently been published to treat heart failure, but most clinical trials leading to these recommendations tended to exclude older adults.

Older adults are at higher risk of falls and severe consequences of falls. All heart failure treatments are at risk of causing a fall through different mechanisms.

Based on the World Health Organization global database, the main objective of this study is to investigate the association between heart failure pharmacological treatments and the report of a fall in the database.

A disproportionality analysis will be performed. It will aim to assess whether some classes of heart failure drugs, and within these classes some individual drugs, are associated with a report of a fall.

A sensibilty analysis will also be performed. It will aim to examine the association between takien a heart failure pharmacological treatment, with a heat failure indication and/or a loop diuretic, and the report of a fall.

Conditions

Interventions

DRUG

Heart failure pharmacological treatments

Identify a positive signal for fall with one or more of the recommended pharmacological treatments for heart failure

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-02
Primary Completion
2025-04-01
Completion
2025-07-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07150754 on ClinicalTrials.gov